Clinical Trial Update: Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of letermovir (Prevymis) for prevention of cytomegalovirus infection in kidney and pancreas transplant recipients is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• PREVYMIS (letermovir)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Cytomegalovirus Infections, Kidney Transplant Infection | Phase 3 | Status: RECRUITING